top of page

Search this site

537 results found with an empty search

  • Update: Advancing the use of SNOMED CT for research in Germany

    Update: Advancing the use of SNOMED CT for research in Germany Back 29 Jun 2020 Back SNOMED CT was recently introduced in Germany as part of the Medical Informatics Initiative (MII), a project funded by the German Federal Ministry of Education and Research (BMBF). A three-year “pilot phase” was launched in mid-March ( press release of the BMBF ). The “pilot licence” is initially limited to participants and project partners of MII. The BMBF will pay the licence fees. During the “pilot phase” the TMF - Technology, Methods and Infrastructure for Networked Medical Research serves as the National Release Centre ( German National Release Centre website ). The MII was created to close the gap between research and healthcare. All of Germany’s university hospitals have joined forces with research institutions, businesses, health insurers, and patient advocacy groups to create a framework that harnesses research findings to the direct benefit of patients. The aim of the MII is to enhance research and patient care through the sharing and use of data from healthcare and from clinical and biomedical research – across multiple entities and sites, while ensuring robust data protection and security. Against this background SNOMED CT is to be used as an overall reference terminology to enable interoperability and multi-site data sharing. After the press conference, the NRC was set up together with SNOMED International. The application process was defined and communicated, as well as first trainings were initiated. The first SNOMED-CT license was already granted on 25 March ( TMF-News ). Since then, more than 40 organizations have received a license. Following this successful start, the next stage is now looming on the horizon: the German Federal Ministry of Health has announced in a draft law that it will acquire national membership in order to establish a continuation of the use of SNOMED CT for the healthcare sector. More updates will be available on a regular basis. Follow @TMF_eV and @Snomedct for more information.

  • Get SNOMED CT | SNOMED International

    Access SNOMED CT, the world’s most comprehensive clinical terminology, through a variety of flexible membership, licensing and fee exemption options. Get SNOMED CT Access the world’s most comprehensive clinical terminology through a variety of flexible membership, licensing and fee exemption options. As a Member or licensee, you join an international community with shared assets, common needs, and a commitment to collaboratively improving the health of people worldwide. Membership Licensing Fee exemptions Contact us Membership SNOMED International is a strong Member-owned and driven organization, having demonstrated growth in Membership each year since inception. Members of SNOMED International can be an agency of a national government, or another body (such as a corporation or regional government agency) endorsed by an appropriate national government authority within the territory it represents. If you are deploying SNOMED CT in a Member country , please register your use with the National Release Center (NRC) of that country (unless your country has MLDS access, when this service should instead be used). SNOMED International does not charge for Affiliate Licensing or for use of SNOMED CT in Member countries. Learn more Licensing SNOMED International does not charge for use of SNOMED CT in SNOMED International Member countries or territories. Charges may apply for affiliate use of SNOMED CT in non-Member territories and are calculated based on use as well as the territory as determined by the World Bank. If you are using and/or deploying SNOMED CT in a non-Member country/territory, you are required to apply for a license through the Member Licensing & Distribution Service (MLDS) on an annual basis. All license holders in non-Member countries or territories are required to submit a Statement of Usage via MLDS on an annual basis. Invoices are issued once annually. Learn more Download the Affiliate License Agreement Fee exemptions Fee exemptions may be applied for SNOMED CT deployments in non-Member territories. Learn more Contact us Do you have questions about SNOMED International membership, licensing or fee exemptions? For a fee calculation or estimate, please contact info@snomed.org with information about your intended use. Other modes of deployment e.g. web applications and browsers, will require special permission and fees applied. Learn more Events Annual Business Meetings, Expo, and SNOMED CT Web Series Learn more Learn more Explore the wide range of resources available to our community of practice

  • Value Proposition | SNOMED International

    SNOMED International is a not-for-profit organization that owns, administers and develops SNOMED CT, the world’s most comprehensive clinical terminology. Visit www.snomed.org for product and service information, stakeholder implementation resources and news about SNOMED CT. Explore the Value of SNOMED CT This interactive platform presents SNOMED CT stakeholder value propositions along with evidence that SNOMED CT adds measurable value to a broad range of primary and secondary health processes leveraging SNOMED CT encoded data to deliver improved patient outcomes. Read the executive summary SNOMED CT is a best-in-class, core clinical reference terminology that is well-designed, comprehensive, serves multiple uses, is widely adopted, and enables improved patient outcomes Question A core clinical reference terminology Several names are given to systems of standardized terms or concepts, such as SNOMED CT. It can be referred to as a terminology, a vocabulary, or a lexicon. These names are all synonymous. The semantic network features of SNOMED CT are the same as what exists in ontologies. SNOMED CT is a terminology built on an ontological foundation (i.e. it looks and acts like an ontology). Ideally, controlled terminologies (vocabularies) should have twelve features, as outlined in the seminal article by Dr. James Cimino. SNOMED CT does in fact adhere to all the twelve features, some of which allow it to be differentiated from other classification systems. As a terminology, SNOMED CT is fit-for-purpose. The European-wide ASSESS CT project, integrated a broad range of stakeholders, and investigated the fitness of the international clinical terminology SNOMED CT as a potential standard for EU-wide eHealth deployments. Assess CT deemed SNOMED CT the best available core reference terminology for cross-border, national and regional eHealth deployments in Europe. Learn more about SNOMED CT Answer What is SNOMED CT? Understand SNOMED CT through the example of Viral Pneumonia Click here 5 things that make SNOMED CT unique Core Reference Terminology SNOMED CT is integrated to over 20 other clinical terminologies and classification systems. It is the core reference terminology in the clinical terminology ecosystem. Learn more Content For terminologies “content is paramount”. SNOMED CT, with over 350,000 concepts is the most comprehensive and fine-grained clinical terminology. It has 3-4 times more content than the next largest clinical terminologies. Learn more Semantic Network SNOMED CT has a machine-readable semantic network, whereas other terminologies do not. SNOMED CT's semantic network differentiates it from other clinical terminologies, especially in its capability to carry out analytics and research. Learn more Broad Use SNOMED CT is commonly used for documenting problem lists, procedures, clinical findings and diseases in clinical information, health data and analytics and interoperability solutions. Learn more National Mandates SNOMED CT is mandated for use in many countries, most notably: U.S.A. with Meaningful Use U.K.’s NHS policy that all GP systems will use SNOMED CT Australia mandating SNOMED CT as the preferred national solution for a clinical terminology as endorsed by the Australian Health Ministers’ Advisory Council. Learn more The value of SNOMED CT for stakeholders Policy Makers Patients & Citizens Care Providers Vendors Implementers Researchers, etc. Collaboration Partners Members Stakeholder value proposition Where is SNOMED CT used? SNOMED CT-embedded Clinical Information Systems, Health Data & Analytics Platforms, and/or Interoperability Solutions are used in the following ways Research Conducting clinical research, laboratory research and scientific research. Data Entry and Integration The recording & integration of SNOMED CT in clinical information systems and health data & analytics platforms. Clinical Information Sharing The electronic exchange of clinical data and documents among Care Providers along the continuum of care, often using interoperability solutions. Research Creating historical summaries, doing point-of-care reporting and using clinical decision support. Population Analytics Conducting trend & comparative analysis, pharmacovigilence and clinical audit. Management Analytics Conducting trend & comparative analysis and health system value analysis. SNOMED CT Case Studies A Demonstrated Case for Investment: Real World Use Learn more AEHRC and CSIRO (Australia) a look into the current and future possibilities for SNOMED CT use in artificial intelligence. Learn more Honghu Public Health Surveillance (COVID-19) a description of the SNOMED-CT-embedded Honghu Hybrid System that supported policy makers and public health officials with COVID-19 surveillance and control Learn more OHDSI the SNOMED CT-embedded OMOP CDM, and the benefits obtained from research projects using the OHDSI research collaborative Learn more University of Nebraska Medical Centre the benefits obtained from the SNOMED CT-embedded i2B2 data warehouse and its use for clinical and translational research Learn more Northern Queensland Primary Health Network and the Mackay Hospital and Health Service an economic evaluation of the Mackay SNOMED CT-embedded HealthPathways implementation Learn more University of Cambridge Hospitals NHS Foundation Trust the benefits derived from a SNOMED CT-embedded eHospital clinical information system, patient portal and a health data & analytics platform Learn more Barts NHS Trust and the East London Health and Care Partnership the benefits derived from a SNOMED CT-embedded Cerner clinical information system and a regional EHR and data & analytics platform Learn more North York General Hospital the benefits obtained from a SNOMED CT-embedded eCare clinical decision support system Learn more Kaiser Permanente the benefits derived from a SNOMED CT-embedded HealthConnect clinical information system and patient portal, as well as analytics and research Learn more Veterans Health Administration the cost benefit analysis of the SNOMED CT-embedded VistA system, as well as the benefits derived from the Veterans Health Information Exchange (VHIE). Click for our approach The Case for Investment identifies why a country invests resources to implement SNOMED CT. Download the Case for Investment Why would a country or hospital entity invest resources to implement SNOMED CT? Desired Value + Potential Value + Demonstrated Value + Future Value Download the full report Learn more What value does a country or healthcare entity desire from a clinical terminology? Learn more What potential value does SNOMED CT provide to a specific country or a healthcare entity? Learn more What demonstrated value has SNOMED CT provided to a country or a healthcare entity in the past? Learn more What are the future opportunities for SNOMED CT? Case study assumptions Download the case studies The global language of healthcare SNOMED International 1 Kingdom Street, Paddington London, W2 6BD United Kingdom Tel: +44 (0)203 755 0974 Email: info@snomed.org Privacy SNOMED International

  • SNOMED CT entirely translated into Dutch and French by Belgian NRC

    SNOMED CT entirely translated into Dutch and French by Belgian NRC Back 17 Sept 2020 Back Various stakeholders in the Belgian healthcare sector have been expressing their need to quickly access as many translated SNOMED CT terms as possible, both in Dutch and French. To respond to this need, the Belgian National Release Centre has, since the end of 2019, made one or more Dutch and French translation(s) available for each SNOMED CT concept that can be accessed through a local platform. These translations were compiled from various reputable sources. They have not yet been completely included in the validated Belgian Extension because they have not yet gone through the entire quality assurance process. With this project, stakeholders have the opportunity to consult or to use the complete translation in a test environment. Their feedback to the National Release Centre (NRC) will be used to further correct or validate the translations. As well, the Belgian NRC is now releasing the alpha version of all translations as a separate "product." This Belgian Alpha Release will be released shortly after the official Belgian Extension in an RF2-format in September and will be available for download through Belgium’s Member Licensing and Distribution Service .

  • MaRS Savvy

    MaRS Savvy Back MaRS Savvy Vendor Overview MaRS Savvy is a medical technology and clinical intelligence initiative focused on mathematical models, anonymization, and structured aggregation of medical data for next-generation clinical workflows and AI-assisted healthcare systems. The project currently develops three core concepts: • Fibonacci Health Algorithm – a medical data anonymization and transformation framework designed to convert sensitive clinical information into mathematically structured representations suitable for secure processing and interoperability. • MaRS Digital Genome – a structured aggregation system capable of compressing and integrating multiple medical parameters into unified informational strings while preserving diagnostic and reverse sense. • PGD (Postprandial Glycemic Dynamic) – a metabolic mathematical model based on glucose exposure over time (mg/dL × min), designed as a measurable metabolic unit for diabetes, metabolism, and glycemic pattern analysis. The initiative explores highly compressed, physician-readable, and machine-processable medical representations intended for metabolic assessment, diabetes management, vascular medicine, longitudinal monitoring, AI-assisted interpretation, and future EMR / SNOMED CT interoperability. MaRS Savvy combines classical clinical reasoning, mathematical abstraction, medical semiology, and computational logic into a unified physician-oriented framework designed to reduce informational fragmentation in medicine. The long-term objective of the project is the development of explainable and secure medical intelligence architectures capable of augmenting human clinical judgment. SNOMED CT-enabled solutions The project currently develops three complementary concepts: • Fibonacci Health Algorithm – a medical data anonymization and transformation framework designed for secure patient processing within EMR environments. While not a SNOMED CT-enabled terminology structure itself, it is designed to operate alongside SNOMED CT-standardized medical systems and interoperable clinical architectures. • MaRS Digital Genome – a SNOMED CT-enabled semantic aggregation and compression system capable of integrating large quantities of standardized medical information into unified informational medical strings. The system is designed as a reversible architecture: complex medical datasets → compressed representation → simplified manipulation and interpretation → reconstruction of the original structured medical information. • PGD (Postprandial Glycemic Dynamic) – a simplified mathematical metabolic model based on glucose exposure over time (mg/dL × min), designed to extend and modulate classical glycemic load mathematics into a more clinically applicable and monitorable metabolic parameter for diabetes and metabolic monitoring systems. Together, these concepts explore physician-oriented architectures for secure medical anonymization, semantic interoperability, mathematical metabolic modeling, and next-generation EMR / SNOMED CT-compatible clinical intelligence systems. Scope of services Analytics, Artificial Intelligence, Chronic disease, Clinical coding, Clinical documentation, EHR, EMR, Lab, Mapping, Telehealth Downloadable documents Office Republicii 56 Bolintin Vale Giurgiu Romania 085100 Contact details Vicentiu Bogdan Ion Marciu Dr. Eng Email: contact@cardionet.live Regions where operational Europe

  • Other stakeholders | SNOMED International

    Care providers, administrators, policy makers, knowledge producers and patients and citizens complete the SNOMED CT stakeholder landscape. Other stakeholders Care providers, administrators, policy makers, knowledge producers and patients and citizens complete the SNOMED CT stakeholder landscape. Learn more at value.snomed.org Care providers SNOMED CT makes it easier for data to be portable from one system to another. Designed by clinicians for clinicians, it enables a unique partnership with technologies. SNOMED international partners with other standards development bodes to create and maintain products to support the implementation of SNOMED CT with other standards supporting interoperability. Learn more Health care administrators SNOMED CT enables accurate and targeted access to relevant information, reducing costly duplications and errors. It enhances audits of care delivery by enabling detailed analysis of clinical records by leveraging the structure of SNOMED CT. Learn more Policy makers SNOMED CT enables links between clinical records and existing clinical guidelines or protocols. It supports the development of adequate evidence for use in the development of clinical guidelines. Learn more Knowledge producers SNOMED CT allows knowledge producers to effectively develop and maintain knowledge products by providing a standard way to encode and connect clinical information contained within patient charts, decision support tools and knowledge resources. It provides a standard way to encode clinical criteria for reuse across a range of clinical, knowledge management and monitoring tools. Learn more Patients and citizens SNOMED CT decreases the need to repeat health history. The detail provided within SNOMED CT allows clinicians to accurately record the specific details relating to a patient across all information fields with an EHR. It plays an important part in medication reconciliation, the awareness of which is critical to patient knowledge. Learn more Learn more Get involved Find out how you can get involved Learn more Education Our education program is designed to enable users to maximize their knowledge of SNOMED CT Care providers Health care administrators Policy makers Knowledge producers Patients

  • amorphous-ai

    Imagine hospital notes transforming themselves into research-grade evidence before the night shift ends: built in Oxford, Striata, a SNOMED-powered AI Scientist ingests raw text, de-identifies it, and maps every concept to SNOMED CT (and companion vocabularies) in real time. Once structured, its multi-agent engine sweeps across diagnoses, medications, age, comorbidities, seasonal trends and workflow metrics, plotting hidden patterns, proposing testable hypotheses, running statistics and flagging bias, then hands users publication-ready reports. Early pilots, including Latvia's NHS, show Striata compresses weeks of analyst labour into minutes, turning any ward into a discovery hub without adding to workloads. By fusing large language model reasoning with SNOMED's formal logic it delivers faster scientific discovery, rapid pharmacovigilance, sharper equity audits and instant operational feedback. Back View Map Amorphous AI The Future Is Here: An AI Scientist for Every Hospital Read More Country / Region EMEA Tags Artificial intelligence, Data analytics, EHDS (European Health Data Space), Innovation, Research, Tooling Imagine hospital notes transforming themselves into research-grade evidence before the night shift ends: built in Oxford, Striata, a SNOMED-powered AI Scientist ingests raw text, de-identifies it, and maps every concept to SNOMED CT (and companion vocabularies) in real time. Once structured, its multi-agent engine sweeps across diagnoses, medications, age, comorbidities, seasonal trends and workflow metrics, plotting hidden patterns, proposing testable hypotheses, running statistics and flagging bias, then hands users publication-ready reports. Early pilots, including Latvia's NHS, show Striata compresses weeks of analyst labour into minutes, turning any ward into a discovery hub without adding to workloads. By fusing large language model reasoning with SNOMED's formal logic it delivers faster scientific discovery, rapid pharmacovigilance, sharper equity audits and instant operational feedback. Description Oxford-based Amorphous AI has developed Striata, a cutting-edge multi-agent AI system designed to autonomously transform raw clinical text into actionable insights in real-time. Striata's cooperative AI agents seamlessly perform patient data de-identification, precise SNOMED CT mapping of clinical entities, and execute automated research cycles that include: * Data Exploration ‚ Systematic and deep analysis of clinical data across demographics, timeframes, and disease states. * Dynamic Visualization ‚ Real-time graphical representations that reveal subtle or complex clinical patterns. * Hypothesis Generation ‚ Automatic identification of clinically significant associations, such as medication risks and operational inefficiencies. * Statistical Testing & Bias Detection ‚ Robust validation processes, including successful autonomous detection of intentionally hidden synthetic drug-outcome associations in a specially constructed benchmark dataset. * Automated Reporting ‚ Generation of detailed, regulator-compliant reports covering methodologies, findings, statistical rigor, and identified limitations. In this project, we generated a synthetic dataset containing ground truths, such as associations between drugs and outcomes. We will present results of this benchmark, showcasing Striata's ability to mine complex health data for insights on par with world-class research teams at a fraction of the cost. Scope SNOMED's rich semantic structure provides ideal support for sophisticated, algorithmic reasoning. Internationally recognized standard ensuring interoperability across global healthcare and regulatory bodies. Essential compatibility with EHDS and FHIR standards, enabling healthcare providers to comply seamlessly with emerging European regulations. Frequent and comprehensive updates allow for rapid integration of novel clinical insights and therapeutic interventions. How SNOMED CT will be used Canonical Encoding ‚ Clinical entities, including diagnoses, medications, procedures, and observations, are standardized to SNOMED identifiers, maintaining nuance through advanced post-coordination techniques. Ontology-Based Reasoning ‚Leverages SNOMED's semantic hierarchy and causal relationships to dynamically refine patient cohorts without human-driven rules. Quality Control with Snowstorm ‚Ensures accuracy and quality control of SNOMED mappings, automatically identifying and rectifying discrepancies following SNOMED updates. Why SNOMED CT will be used Contact More information Learn more Get SNOMED CT Information about our license and fee structure Learn more Learn more Explore the wide range of resources available to our community of practice

  • First Databank UK Ltd.

    First Databank UK Ltd. Back First Databank UK Ltd. Vendor Overview FDB (First Databank) is the leading provider of drug and medical device knowledge that helps healthcare professionals make precise decisions. With thousands of customers worldwide and four decades of experience, FDB enables our developer partners to deliver actionable solutions that help improve patient safety, quality, and healthcare outcomes. SNOMED CT-enabled solutions FDB Multilex provides comprehensive, independent, medications information and is the UK’s most widely used drug database and e-prescribing decision support solution, deployed in over 10,000 sites. FDB Multilex supports safer e-prescribing and dispensing across a range of healthcare settings. Multilex uses SNOMED to support contraindication checking for prescribed drugs. SNOMED is also used to allow users to navigate from a prescribed drug to a diagnosis for recording in an Electronic Health Record Product. Set links enabled by SNOMED are used for secondary care prescribing where most drugs are prescribed by VTM but not preparation strength or formulation, and also for Ingredient links for allergy recording. FDB OptimiseRx is the leading medicines optimisation solution for primary care in the UK. FDB OptimiseRx combines evidence-based best practice, safety and cost-effective prescribing messages, and delivers them in real time at the point of care during the prescribing workflow. SNOMED is used in condition checking for OptimiseRx alternative product screening and for Condition Term authoring in OptimiseRx complex messages. Across both solutions, SNOMED is used in value sets for the following: Admin Method Admin Site Base Formulation DXID (Diagnosis group) Ingredient Product Set Route Unit of measure The main areas of SNOMED linked to include, but are not limited to: Procedure Substance Situation with explicit context Clinical finding Trade Family Virtual therapeutic moiety Morphological abnormality Scope of services Analytics, Chronic disease, Clinical documentation, Drug, EHR, EMR, Oncology, Pharmacy Downloadable documents Office Swallowtail House Grenadier Road Exeter Devon EX1 3LH UnitedKingdom https://fdbhealthdata.com/ Contact details Ian Arrowsmith Head of Clinical Content Operations +44 (0) 1392 440 100 contact@fdbhealth.com Regions where operational Global

  • First Member from the Caribbean region, Jamaica adopts SNOMED as a needed element of its digital health transformation

    First Member from the Caribbean region, Jamaica adopts SNOMED as a needed element of its digital health transformation Back 2 Jun 2023 Back SNOMED International is pleased to announce that Jamaica has joined the global SNOMED CT community, becoming SNOMED International’s inaugural Member from the Caribbean region. Jamaica, the third largest island in the Caribbean Sea, boasts a population of nearly 3 million. Currently, Jamaica is undergoing a major digital transformation of its healthcare system, spearheaded by the national EHR pilot and health data exchange platform. These cutting-edge initiatives will empower patients to access their healthcare data and streamline transitions between public and private healthcare systems. By leveraging technology to improve healthcare access and quality, Jamaica is poised to make significant strides in enhancing the well-being of its citizens, while setting a compelling example for other nations in the region to follow. Founded in 2007 by nine charter nations, SNOMED International is a not-for-profit, member-owned and driven international organization. Jamaica’s adoption of SNOMED CT, the world’s most comprehensive health terminology, is an important part of its digital health transformation: not only does it provide access to SNOMED CT and SNOMED International’s related products and services, but it also opens the door to the broad expertise of a global community of stakeholders, including other Members, collaboration partners, researchers, policy-makers, implementers, vendors, care providers, and patients and citizens. Learn more about the varied stakeholders contributing to the use and ongoing development of SNOMED CT at www.value.snomed.org . Joining a community of 48 global Members, Jamaica’s Ministry of Health & Wellness will serve as the National Release Centre for SNOMED CT. The Ministry will appoint representatives to the General Assembly and the Member Forum, the governance bodies that shape and guide SNOMED International projects and products, promote consultation and communication between SNOMED International and Members and make binding organizational decisions. “We are thrilled to welcome our first Member of the Caribbean region,” said SNOMED International CEO Don Sweete. “The implementation of SNOMED CT in Jamaica aligns with and supports the country’s commitment to digitally transforming its health system and will contribute to improved patient outcomes for Jamaica’s citizens.” Learn more about Jamaica’s Ministry of Health & Wellness . Visit Jamaica’s Member page on the SNOMED International website to view the country’s representatives to the Member Forum and the General Assembly. To learn more about SNOMED International and SNOMED CT, visit www.snomed.org . About the Jamaican Ministry of Health & Wellness The Ministry of Health (MOH) is the pre-eminent Government organization whose mandate is “to ensure the provision of quality health services and to promote healthy lifestyles and environmental practices.” The Ministry and its Regional Health Authorities, agencies and related organizations make up the public health system and are responsible for health care delivery across the island. Jamaica’s health vision is: “Healthy People, Healthy Environment.” It is one which envisages a health system that is client-centred and guarantees access to quality health care for every person in its population, at reasonable costs, and which takes into account the needs of the vulnerable. It is one which seeks to provide information and to educate the populace, to facilitate individuals taking responsibility for their own health, making informed decisions and adopting healthy lifestyle habits. All this, within a clean, healthy environment where families and communities actively participate and are integrated into the system of health. About SNOMED International SNOMED International is a not-for-profit organization that owns and develops SNOMED CT, the world's most comprehensive healthcare terminology product. We play an essential role in improving the health of humankind by determining standards for a codified language that represents groups of clinical terms. This enables healthcare information to be exchanged globally for the benefit of patients and other stakeholders. We are committed to the rigorous evolution of our products and services, to deliver continuous innovation for the global healthcare community. SNOMED International is the trading name of the International Health Terminology Standards Development Organization (IHTSDO.)

  • Ontology 2.0 deepens LOINC®-SNOMED collaboration, speeds global lab interoperability

    Ontology 2.0 deepens LOINC®-SNOMED collaboration, speeds global lab interoperability Back 1 Oct 2025 Back INDIANAPOLIS, US and LONDON, UK – October 3, 2025 – Regenstrief Institute and SNOMED International have released LOINC® Ontology 2.0, the next version of The LOINC Ontology: A LOINC and SNOMED CT Interoperability Solution and a significant advance in their ongoing collaboration to streamline the exchange and use of health data worldwide. This version expands the Ontology with approximately 6,000 additional concepts, with more than 2,500 new “Orderable Grouper” concepts that provide practical, higher-level groupings for laboratory orders. By introducing this organization, called LABORDERS.ONTOLOGY, the partners are deepening their relationship and making it easier for implementers to deploy a broader range of LOINC and SNOMED CT concepts across health information systems. Developed as a LOINC and SNOMED CT interoperability solution, the LOINC Ontology helps organizations that implement different combinations of the two standards meet clinical and regulatory requirements with a single, complementary approach. SNOMED CT supplies the computable framework, while LOINC contributes rich laboratory and pathology content in a widely understood format – benefiting implementers globally, including those in countries that do not yet use LOINC. The update is in response to international users who requested clearer navigation and application. Instead of working with a flat list of tens of thousands of concepts, implementers can now use this organization hierarchy to locate and manage related tests more efficiently. Version 2.0 continues to support the ongoing development of standardized laboratory orders and results for exchange and use in health data systems globally. Each grouper combines component, system (specimen) and a new “measurement” property to group related result concepts, giving users an at-a-glance structure that encompasses three or more related tests. These concepts are designed for ordering, not for reporting results, and align with the granularity typical of laboratory order catalogs. “Many laboratories need order codes that are more abstract than result codes,” said MarjorieRallins, DPM, M.S., executive director of Health Data Standards at Regenstrief, which oversees LOINC. “With these new Orderable Grouper concepts, we’re giving the community a better way to align laboratory ordering practices with the rich specificity of LOINC. The LOINC Ontology is novel and transformative in providing clinical observation content in an integrated format that accelerates interoperability and supports stakeholders with meeting clinical and regulatory requirements.” “Significant commitment and collaboration have gone into producing this Ontology,” said Don Sweete, CEO of SNOMED International. “SNOMED CT contributes the computable clinical framework, rigorous semantics and terminology that anchor the Ontology 2.0 hierarchy, enabling navigation, decision support, analytics and global interoperability alongside LOINC’s laboratory content. It’s an excellent illustration of how we’ve leveraged our mutual expertise to further the goal of interoperability for implementers globally.” Key highlights of LOINC Ontology 2.0 include: ONTOLOGY concepts: Each combines component, system (specimen) and a new “measurement” property to group related result concepts. Created for ordering, not results: These concepts provide a granularity consistent with typical laboratory order catalogs but should not be sent as result codes. Clearer navigation: Users gain an “at a glance” structure that encompass three or more related result concepts for easier browsing. Guidance and training: Tutorials and educational resources will be developed to support correct implementation and prevent misuse. The LOINC Ontology is fully owned by Regenstrief Institute and is available free of charge under the existing LOINC royalty-free license. SNOMED International members and users can access LOINC in the same format as SNOMED CT. Each organization retains editorial control of its respective standard. SNOMED International, a not-for-profit organization governed by 50 global members, sets global standards for health terminology. Its comprehensive, multilingual SNOMED CT enables healthcare professionals to capture, share and analyze patient care data to support safe, effective health information exchange. In 2022, the two organizations signed a milestone agreement to create a LOINC extension of SNOMED CT. This built on a partnership established in 2013 that linked SNOMED’s clinical semantics to LOINC’s observational concepts, improving data exchange and interoperability across health systems. For more information and to browse and download the Ontology, visit https://loincsnomed.org . This press release was originally published on the Regenstrief Institute website on September 29, 2025. About LOINC® LOINC® was created in 1994 at Regenstrief Institute to facilitate interoperability in healthcare. There was a growing trend to send clinical data electronically between healthcare entities, a practice that has now become ubiquitous. Today, it contains more than 108,000 concepts for everything from an albumin level to a zygomatic arch X-ray report. For each concept, LOINC contains many other rich details, such as synonyms, units of measure and carefully crafted descriptions. About SNOMED International SNOMED International is a not-for-profit organization that owns and develops SNOMED CT, the world’s most comprehensive healthcare terminology product. We play an essential role in improving the health of humankind by determining standards for a codified language that represents groups of clinical terms. This enables healthcare information to be exchanged globally for the benefit of patients and other stakeholders. We are committed to the rigorous evolution of our products and services, to deliver continuous innovation for the global healthcare community. SNOMED International is the trading name of the International Health Terminology Standards Development Organisation. https://www.snomed.org . About Regenstrief Institute Regenstrief Institute, based in Indianapolis, is a globally renowned medical research organization with expertise and innovation in aging, health services and biomedical informatics research, global health standards and data stewardship. The organization collaborates with local, state, national and international public and private sector partners to develop, conduct, disseminate and implement impactful scientific research and solutions in health systems and across communities. The Institute’s vision is to engage in pioneering, transformative, interdisciplinary solutions for a healthier world.

  • Digital China Health

    Digital China Health Back Digital China Health Education Partner In 2019, Digital China Health and SNOMED International struck an agreement to deliver mutually agreed upon SNOMED CT educational content including the organization’s clinically and technically curated Foundation and Implementation courses, with the potential to also offer the organizations suite of Authoring courses for delivery. As part of this agreement, Digital China Health will serve as an extension of the SNOMED International Education Program within China and be empowered to issue course completion certificates and certifications as applicable. Additional information Visit Education at SNOMED International or contact elearning@snomed.org for more information. Press Release: November 2019: SNOMED International signs SNOMED CT education delivery agreement with Digital China Health Technologies

  • Global Medical Device Nomenclature Agency

    Global Medical Device Nomenclature Agency Back Global Medical Device Nomenclature Agency Standards Partner In 2012, SNOMED International and Global Medical Device Nomenclature Agency (GMDNA), the organization responsible for the international Global Medical Device Nomenclature© (GMDN), signed a 5 year Cooperation Agreement. A key focus of the Agreement was to exchange, harmonize and incorporate medical device term descriptions from each other to enhance the end-to-end patient risk and safety use cases in healthcare systems incorporating medical device information. Additional information Initial work was the incorporation of relevant GMDN© content into SNOMED CT and production of a map from SNOMED CT to GMDN©. As part of ongoing maintenance, new content continues to be included in each SNOMED CT International release, with the SNOMED CT to GMDN© map also updated inline with these releases. Emerging requirements are the need to link EHR information about medical devices to regulation and any safety issues. Globally, medical device regulators are introducing rules governing unique device identification (UDI). As a result, it is important for SNOMED International to understand its stakeholder requirements for medical device content and its relationship with GMDN© and other medical device nomenclatures as medical device regulation is updated across the world.

Search Results

bottom of page